All stories tagged market analysis on VentureGrill.
Global venture funding into biotech startups has maintained a consistent trajectory, hovering between $36 billion and $40 billion annually, even as AI investment experiences dramatic shifts.
Instinct’s latest capital injection highlights a persistent investor preference for AI workflow automation tools despite a broader slowdown in megadeal activity.
UK fintech funding has hit a decade low, reflecting a broader shift in investor sentiment as capital pivots away from speculative growth toward proven unit economics.
Global venture funding surged in July, reaching an unprecedented $65 billion and marking a 100% year-over-year increase, driven by a record 14 billion-dollar rounds.